By Sean O’Connell, Alison Schurick and Emily Kesler ( February 28, 2025, 6:01 PM EST) -- In U.S. v. Regeneron Pharmaceuticals Inc., decided by the U.S. Court of Appeals for the First Circuit on Feb. 18, the government alleged that the company violated the Anti-Kickback Statute by covering patient copayments through a charitable foundation, thereby inducing physicians to prescribe a vision drug, Eylea....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.